Dr. Katsivas is an associate physician at the Owen Clinic at the University of California, San Diego.
I think we have great treatment. The problem is not really treatment efficacy. The problem is treatment availability and uptick. So that's going to be the battle in the following years. Get many people on treatment, as many as we can, and then also expand treatment to prophylaxis, as has been suggested.
There are a lot of barriers to that. It feels sometimes defeating, working in the clinic and being a clinician, where you see really only the people that come to clinic regularly -- what we call engaged in care. But really, studies have shown that 60% or more of people are not really engaged in care. And these are the people I cannot work with. And I would like to work with these people.
This work that we did here and we're presenting is one step toward getting to that by testing, and by expanding testing opportunities for people. Unfortunately, even our medical students don't seem to know, or to be very much aware, of the guidelines for universal testing. And these are the doctors of the future. That's going to be an issue that needs to be addressed. So, expand testing opportunities, expand treatment opportunities, and make treatment available for many more people within the U.S., let alone worldwide.